Regulation of AMP-activated protein kinase by natural and synthetic activators - Test2 - elhamkhani - TriplyDB

Regulation of AMP-activated protein kinase by natural and synthetic activators

Regulation of AMP-activated protein kinase by natural and synthetic activators

http://www.wikidata.org/entity/Q26767334

about

Relevance of Endoplasmic Reticulum Stress Cell Signaling in Liver Cold Ischemia Reperfusion Injury Treatment of nonalcoholic fatty liver disease: role of AMPK.Effects of turmeric curcuminoids and metformin against central sensitivity to pain in mice.Emerging Metabolic Therapies in Pulmonary Arterial Hypertension.Dissecting the role of AMP-activated protein kinase in human diseases.Prolonged Growth Hormone/Insulin/Insulin-like Growth Factor Nutrient Response Signaling Pathway as a Silent Killer of Stem Cells and a Culprit in Aging.CHIP(-/-)-Mouse Liver: Adiponectin-AMPK-FOXO-Activation Overrides CYP2E1-Elicited JNK1-Activation, Delaying Onset of NASH: Therapeutic Implications.AMPKα Is Suppressed in Bladder Cancer through Macrophage-Mediated Mechanisms.AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs.Structure and Regulation of AMPK.Syringaresinol-4-O-β-d-glucoside alters lipid and glucose metabolism in HepG2 cells and C2C12 myotubes.Thalidezine, a novel AMPK activator, eliminates apoptosis-resistant cancer cells through energy-mediated autophagic cell death.Targeting Mitochondrial Dysfunction for the Treatment of Diabetic Complications: Pharmacological Interventions through Natural Products AMPK and cardiac remodelling.Keeping the home fires burning: AMP-activated protein kinase.AMPK in skeletal muscle function and metabolism.A concise review on advances in development of small molecule anti-inflammatory therapeutics emphasising AMPK: An emerging target.Phosphorylation of CDC25C by AMP-activated protein kinase mediates a metabolic checkpoint during cell-cycle G2/M-phase transition.Nrf2 attenuates inflammatory response in COPD/emphysema: Crosstalk with Wnt3a/β-catenin and AMPK pathways.The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting.Mitochondria-derived ROS activate AMP-activated protein kinase (AMPK) indirectly

P2860

Q26745583-62C8B938-8D19-48EC-9B39-3ED631AC0A68 Q30248230-C2BC931B-2494-497F-956F-4EB2A7AEDEE2 Q33552951-BDDA70E3-1629-4075-8A32-C159EE94778B Q33608219-055108B7-3166-4DE1-B9EB-694F68DC1D7D Q33682914-BD836263-9592-4F14-A14D-B62A76B4587B Q33861285-554256DC-B9CF-4E24-963F-298758D769C7 Q37089148-BDFA71DF-1C4B-4FF6-8C6E-0610D0AF4555 Q37482647-2AD42415-65FE-498C-9EB1-B82FC82C47D3 Q38652124-89F245F3-68E2-422F-A9D3-AD82386CA5BE Q38998390-C65E1F4B-5CEE-4811-A76C-95670DFA6CE3 Q41068789-7D241C99-FD51-4FE2-8396-406927E45611 Q42244820-30B04EF6-7F42-4229-B1C3-0BC5FD63F2F0 Q42278797-25601C78-5A8B-4072-AA29-090B13F6D240 Q47369070-EABCFBFD-A9AF-4FF1-8A0F-9B3E9CABC457 Q47674391-D3381604-A398-4679-BECE-23EE7BF14B6A Q47781006-4AC7CA0F-38C6-4B5F-862F-D9F8E6B93D7E Q51426480-8995A324-DF62-445C-8126-AC9DFE2DE079 Q52375228-3C05E497-6861-4CC1-A8F1-F5465AC4B64E Q52586338-09602674-BFEC-4CD4-9EF4-15952BB43289 Q55653938-9DD195AA-117A-4E36-BDFA-A44514A52A7C Q58714554-45C39BA4-86ED-401F-B6FF-A8261E4ACA56

P2860

Regulation of AMP-activated protein kinase by natural and synthetic activators

http://www.wikidata.org/entity/Q26767334

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Regulation of AMP-activated protein kinase by natural and synthetic activators

@ast

Regulation of AMP-activated protein kinase by natural and synthetic activators

@en

Regulation of AMP-activated protein kinase by natural and synthetic activators

@nl

type

label

Regulation of AMP-activated protein kinase by natural and synthetic activators

@ast

Regulation of AMP-activated protein kinase by natural and synthetic activators

@en

Regulation of AMP-activated protein kinase by natural and synthetic activators

@nl

prefLabel

Regulation of AMP-activated protein kinase by natural and synthetic activators

@ast

Regulation of AMP-activated protein kinase by natural and synthetic activators

@en

Regulation of AMP-activated protein kinase by natural and synthetic activators

@nl

P1433

Q26767334-E1866AA5-2FF7-4DEC-8FD2-9663D8814922

P1476

Q26767334-E11236A7-E1C0-489A-BAE3-CF256E5AE08E

P2093

Q26767334-20EC3DEA-FBCF-4F7A-87D5-4704322A75FF

P2860

Q26767334-00209143-992C-461B-88DD-8565BFF72CF4

Q26767334-006D8BFA-3A93-4C0F-9A9B-6AD59011B141

Q26767334-0503BBDA-A9F3-43B1-88E6-BBE73C4E622A

Q26767334-054051E0-7226-492B-AC55-98F8B54B61EF

Q26767334-05B111E8-71D1-4F03-A45F-D00A44BD9DD7

Q26767334-068C97DB-F052-43AC-8D35-906AE1A3F8C4

Q26767334-06AD5EE9-AC7E-4D22-92B3-54E1CE49C1CA

Q26767334-076ED7FA-60A0-43BE-9350-4DB76A57830F

Q26767334-07CE61A1-22AE-4C50-972F-888D7F1DBED4

Q26767334-07EB3B75-FA51-41F5-9C87-D61234E5E27B

P304

Q26767334-B31C7976-DFDA-4624-BCFA-3B5B11ABF90E

P31

Q26767334-5A9A1C83-7110-4087-A1C7-03FBE86C0CCE

P3181

Q26767334-9AD0EF93-2856-4F25-990C-CE785073DB7F

P356

Q26767334-7DC59D1A-4E34-49CE-84C7-137773341986

P407

Q26767334-29E5A771-22FE-422D-8529-EA5866B7FC1C

P433

Q26767334-00D29A0F-3549-49EF-B0A6-52F73E39D396

P478

Q26767334-36AADCFC-A074-42D1-BF11-D1A017455D34

P577

Q26767334-40A6810A-E4E3-4352-A0DC-F899FBC22033

P5875

Q26767334-E3C1C721-35F7-429C-B874-7F1C565C716C

P698

Q26767334-1A8DFCFD-F4E0-44D6-92E6-A0CA541A64B7

P932

Q26767334-891A0BDB-ED45-4ABE-9E43-C348CCA3BBFB

P3181

P356

J.APSB.2015.06.002

P1433

Acta pharmaceutica Sinica B

P1476

Regulation of AMP-activated protein kinase by natural and synthetic activators

@en

P2093

David Grahame Hardie

http://www.w3.org/2001/XMLSchema#string

P2860

Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade

Genome sequence and gene compaction of the eukaryote parasite Encephalitozoon cuniculi

Structural basis for AMP binding to mammalian AMP-activated protein kinase

Structure of mammalian AMPK and its regulation by ADP

AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation.

CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations

The ancient drug salicylate directly activates AMP-activated protein kinase

The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress

Thrombin activates AMP-activated protein kinase in endothelial cells via a pathway involving Ca2+/calmodulin-dependent protein kinase kinase beta

AMPK activation through mitochondrial regulation results in increased substrate oxidation and improved metabolic parameters in models of diabetes

P304

1-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

124993

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.APSB.2015.06.002

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282534099

http://www.w3.org/2001/XMLSchema#string

P698

26904394

http://www.w3.org/2001/XMLSchema#string

P932

4724661

http://www.w3.org/2001/XMLSchema#string